Drug susceptibility of aAspergillus flavus and A.fumigatus to itraconazole and amphotericin B
Journal of Gorgan University of Medical Sciences. 2014; 15 (4): 66-71
em Inglês, Persa
| IMEMR
| ID: emr-139742
ABSTRACT
Aspergillosis is the most current causative agent of exogenous fungal nosocomial infection. This study was done to evaluate the drug susceptibility of Aspergillus flavus and A.fumigatus to itraconazole and amphotericin B. This Laboratory study was done on 25 Aspergillus fumigatus and 25 Aspergillus flavus species isolated from transplant's patients. Drug susceptibility test was done according to NCCLS M38-P document. Fungal suspensions of mentioned fungi were supplied with ranges 0.5-5x10[4] by spectrophotometer at 530 nm. Serial dilutions of drugs were supplied from 0.03125 to 16 microg/ml and MICs determined following 48h incubation at 35C. Obtained MICs ranges for Aspergillus fumigatus and Aspergillus flavus were 1-4 microg/ml and 0.5-4 micro g/ml for itraconazole, respectively while MICs ranges against Aspergillus fumigatus and Aspergillus flavus were 0.5-2 micro g/ml and 0.25-2 microg/ml for amphotericin B, respectively. Amphotericin B MICs were significantly lower than itraconazole [P<0.05]. Aspergillus flavus and A.fumigatus were susceptible to amphotericin B and itraconazole
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Aspergillus flavus
/
Aspergillus fumigatus
/
Resistência Microbiana a Medicamentos
/
Testes de Sensibilidade Microbiana
/
Anfotericina B
/
Itraconazol
/
Antifúngicos
Limite:
Humanos
Idioma:
Inglês
/
Persa
Revista:
J. Gorgan Univ. Med. Sci.
Ano de publicação:
2014
Similares
MEDLINE
...
LILACS
LIS